Centaur Pharmaceuticals Private Limited Gliclazide Export Data — India (DGFT 2022–2026)

Name: Centaur Pharmaceuticals Private Limited Gliclazide Export Records India — #12 Exporter, 36 Shipments, $1.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Gliclazide

India Pharmaceutical Trade Intelligence

$300.8M238 Suppliers109 CountriesHS 30049099

ExportsIndia → HUNGARY29.3%India → NETHERLANDS29.2%

ImportsUNITED KINGDOM → India$1.0M BULGARIA → India$261.6K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Centaur Pharmaceuticals Private Limited — Gliclazide Exporter #12 | $1.8M Trade Value | TransData Nexus | TransData Nexus

Centaur Pharmaceuticals Private Limited — Gliclazide Exporter Profile

Indian Pharmaceutical Exporter · #12 for Gliclazide · $1.8M export value · DGFT Verified

Centaur Pharmaceuticals Private Limited is the #12 Indian exporter of Gliclazide with $1.8M in export value and 36 verified shipments. Centaur Pharmaceuticals Private Limited holds a 0.6% market share in Gliclazide exports across 9 countries. The company exports 6 pharmaceutical products worth $11.1M across 4 therapeutic categories.

Centaur Pharmaceuticals Private Limited — Gliclazide Export Profile: Buyers & Destinations

Centaur Pharmaceuticals Private Limited Gliclazide export treemap — buyers and destination countries | TransData Nexus

Where Does Centaur Pharmaceuticals Private Limited Export Gliclazide?

Country	Value	Shipments	Share
CANADA	$250.0K	7	24.0%
SLOVAK REPUBLIC	$170.8K	4	16.4%
CROATIA	$136.6K	4	13.1%
GERMANY	$130.3K	15	12.5%
FRANCE

Who Are the Top Buyers of Gliclazide from Centaur Pharmaceuticals Private Limited?

Buyer	Country	Value	Orders
MINT PHARMACEUTICALS INC	CANADA	$200.0K	4
STADA PHARMA SLOVAKIA, S.R.O.	SLOVAK REPUBLIC	$170.8K	4
BELUPO LIJEKOVI KOZMETIKA D D ULICA DANICA	CROATIA	$136.6K	4
MERCKLE GMBH	GERMANY	$130.2K	4
MAP UNITED PHARMACEUTICAL COMPANY	KUWAIT	$100.0K	3
PHOENIX ZDRAVONTNICKE ZASOBOVANIE A S DIALNICNA CESTA	SLOVAKIA	$80.3K	2
LABORATORIO STADA, S.L.U.	SPAIN	$67.2K	2
EG LABO LABORATOIRES EUROGENERIC	FRANCE	$57.7K	2
CENTRE SPECIALITES PHARMACEUTIQUES	FRANCE	$50.0K	1
MINT PHARMACEUTICALS INC.	CANADA	$50.0K	1

Centaur Pharmaceuticals Private Limited supplies Gliclazide to 15 buyers globally. The largest buyer is MINT PHARMACEUTICALS INC (CANADA), followed by STADA PHARMA SLOVAKIA, S.R.O. (SLOVAK REPUBLIC) and BELUPO LIJEKOVI KOZMETIKA D D ULICA DANICA (CROATIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Gliclazide Formulations Does Centaur Pharmaceuticals Private Limited Export?

Product Description / Formulation	Value	Shipments
INDIAN HARMLESS MEDICINES-GLICLAZIDE MOD	$237.9K	6
INDIAN HARMLESS MEDICINES ASOKA MR 60MG/ GLICLAZIDE MODIFIED RELEASE TABLETS 60 MG - 6X10'S - KW EACH MODIFIED RELEAS	$100.0K	2
GLICLAZIDE RETARD TEVA 60 MG /GLICLAZIDEMODIFIED RELEASE TABLETS 60 MG - 3X10`S -NL EACH MODIFIED RELEASE TABLET CONTA	$87.2K	2
INDIAN HARMLESS MEDICINES- GLICLAZIDE EG	$50.0K	1
MINT GLICLAZIDE MR 30MG TABLETS- PACK SI	$50.0K	1
INDIAN HARMLESS MEDICINES: GLIKA 60 MG TABLETS / GLICLAZIDE 60 MG MODIFIED RELEASE TABLETS - 3X10`S - HR EACH MODIFIED R	$50.0K	1
INDIAN HARMLESS MEDICINES: GLIKA 60 MG TABLETS / GLICLAZIDE 60 MG MODIFIED RELEASE TABLETS - 3X10`S - MK EACH MODIFIED R	$50.0K	1
INDIAN HARMLESS MEDICINES - GLICLAZIDE MODIFIED RELEASE TABLETS 60 MG - 12 X 10'S-SK GLICLAZIDE MR STADA 60 MG EACH MO	$50.0K	1
INDIAN HARMLESS MEDICINES MINT GLICLAZIDE MR 30MG-100S GLICLAZIDE MODIFIED RELEASE TABLETS 30MG EACH	$50.0K	1
MINT-GLICLAZIDE MR 60 MG/GLICLAZIDE MODIFIED RELEASE TABLETS 60 MG EACH MODIFIEDRELEASE TABLET CONTAINS:GLICLAZIDE	$50.0K	1

Centaur Pharmaceuticals Private Limited exports 32 distinct Gliclazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is INDIAN HARMLESS MEDICINES-GLICLAZIDE MOD with 6 shipments worth $237.9K.

How Does Centaur Pharmaceuticals Private Limited Compare to Nearest Gliclazide Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
13	INVENTIA HEALTHCARE LIMITED	$2.0M	134	6	$14.8K
14	ALKEM LABORATORIES LIMITED	$2.0M	68	2	$29.2K
12	CENTAUR PHARMACEUTICALS PRIVATE LIMITED ★	$1.8M	36	9	$50.0K
15	WALLACE PHARMACEUTICALS PRIVATE LIMITED	$1.1M	22	1	$50.0K

Centaur Pharmaceuticals Private Limited ranks #12 among 238 Indian Gliclazide exporters. Average shipment value of $50.0K compared to the market average of $287.6K. The closest competitors by value are INVENTIA HEALTHCARE LIMITED and ALKEM LABORATORIES LIMITED.

Which Indian Ports Ship Gliclazide Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	439	11.5%
SAHAR AIR	375	9.8%
JNPT/ NHAVA SHEVA SEA	323	8.4%
SAHAR AIR CARGO ACC (INBOM4)	247	6.4%
DELHI AIR	229	6.0%
JNPT	203	5.3%
DELHI AIR CARGO ACC (INDEL4)	165	4.3%
CMA CGM LOGISTICS PARK ICD	103	2.7%

Geopolitical & Trade Policy Impact on Centaur Pharmaceuticals Private Limited's Gliclazide Exports

Centaur's export operations are currently navigating a complex geopolitical landscape. The ongoing Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to alter trade routes. This has resulted in extended transit times and elevated freight rates, impacting the cost-effectiveness and timeliness of pharmaceutical exports from India to Europe. (livemint.com) For Centaur, which relies heavily on these shipping lanes, such disruptions necessitate strategic adjustments in logistics and supply chain management.

In the United States, the push for pharmaceutical manufacturing reshoring and the imposition of tariffs on imported drugs have introduced additional challenges for Indian exporters. Centaur's acquisition of Bayshore Pharmaceuticals LLC can be seen as a strategic response to these developments, enabling the company to establish a local presence and potentially circumvent some of the trade barriers. (prysm.fi) This move reflects a proactive approach to maintaining competitiveness in a rapidly evolving market.

Furthermore, compliance with the European Union's falsified medicines directive requires stringent adherence to quality and safety standards. For Centaur, ensuring compliance with these regulations is crucial to sustaining and expanding its market share in the EU. The company's commitment to quality is evident in its successful USFDA audits and adherence to Good Manufacturing Practices (GMP). (moneycontrol.com)

Centaur Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Centaur's export operations. The company has demonstrated a strong commitment to quality, as evidenced by its Pune finished dosage facility completing a USFDA audit with zero Form 483 observations, resulting in a No Action Indicated (NAI) compliance status. (moneycontrol.com) This achievement underscores Centaur's adherence to current Good Manufacturing Practices (cGMP) and its dedication to producing high-quality pharmaceutical products.

However, the evolving regulatory landscape, including the EU's falsified medicines directive and the US's emphasis on domestic manufacturing, necessitates continuous vigilance and adaptation. Centaur's proactive measures, such as acquiring U.S.-based entities and ensuring compliance with international standards, position the company to navigate these challenges effectively.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Centaur Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 44 individual customs records matching Centaur Pharmaceuticals Private Limited exporting Gliclazide, covering 32 formulations to 10 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 643+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Gliclazide

Gliclazide

Centaur Pharmaceuticals Private Limited — Gliclazide Exporter Profile

Centaur Pharmaceuticals Private Limited — Gliclazide Export Profile: Buyers & Destinations

Where Does Centaur Pharmaceuticals Private Limited Export Gliclazide?

Who Are the Top Buyers of Gliclazide from Centaur Pharmaceuticals Private Limited?

What Is India's Total Gliclazide Export Value and How Much Does Centaur Pharmaceuticals Private Limited Contribute?

What Is the Average Shipment Value for Centaur Pharmaceuticals Private Limited's Gliclazide Exports?

How Does Centaur Pharmaceuticals Private Limited Compare to Other Indian Gliclazide Exporters?

What Gliclazide Formulations Does Centaur Pharmaceuticals Private Limited Export?

Regulatory Requirements: Exporting Gliclazide to Key Markets

Canada — HC

How Does Centaur Pharmaceuticals Private Limited Compare to Nearest Gliclazide Exporters?

Which Indian Ports Ship Gliclazide Exports?

Geopolitical & Trade Policy Impact on Centaur Pharmaceuticals Private Limited's Gliclazide Exports

Centaur Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards

About Centaur Pharmaceuticals Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Gliclazide Export Data from Centaur Pharmaceuticals Private Limited

Gliclazide Stats

Company Overview

Top Products by Centaur Pharmaceuticals Private Limited

Related Analysis

Need Detailed Export Data?

Data Source